Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


Articles published in Ann Rheum Dis

Retrieve available abstracts of 12 articles:
HTML format



Single Articles


    January 2021
  1. FANOURIAKIS A, Tziolos N, Bertsias G, Boumpas DT, et al
    Update omicronn the diagnosis and management of systemic lupus erythematosus.
    Ann Rheum Dis. 2021;80:14-25.
    PubMed     Abstract available


    May 2020
  2. KUWANA M, Blair C, Takahashi T, Langley J, et al
    Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.
    Ann Rheum Dis. 2020;79:626-634.
    PubMed     Abstract available


    March 2020
  3. XANTHOULI P, Jordan S, Milde N, Marra A, et al
    Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
    Ann Rheum Dis. 2020;79:370-378.
    PubMed     Abstract available


    January 2019
  4. SUN F, Lei Y, Wu W, Guo L, et al
    Two distinct clinical phenotypes of pulmonary arterial hypertension secondary to systemic lupus erythematosus.
    Ann Rheum Dis. 2019;78:148-150.
    PubMed    


    April 2018
  5. BEYER C, Huscher D, Ramming A, Bergmann C, et al
    Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.
    Ann Rheum Dis. 2018;77:626-628.
    PubMed    


    January 2018
  6. MIHAI C, Antic M, Dobrota R, Bonderman D, et al
    Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort.
    Ann Rheum Dis. 2018;77:128-132.
    PubMed     Abstract available


    November 2017
  7. HUANG J, Maier C, Zhang Y, Soare A, et al
    Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis.
    Ann Rheum Dis. 2017;76:1941-1948.
    PubMed     Abstract available


    August 2017
  8. AVOUAC J, Konstantinova I, Guignabert C, Pezet S, et al
    Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension.
    Ann Rheum Dis. 2017 Aug 11. pii: annrheumdis-2016-210821.
    PubMed     Abstract available


  9. KOWAL-BIELECKA O, Fransen J, Avouac J, Becker M, et al
    Update of EULAR recommendations for the treatment of systemic sclerosis.
    Ann Rheum Dis. 2017;76:1327-1339.
    PubMed     Abstract available


    July 2017
  10. COGHLAN JG, Galie N, Barbera JA, Frost AE, et al
    Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
    Ann Rheum Dis. 2017;76:1219-1227.
    PubMed     Abstract available


    February 2017
  11. HUMBERT M, Coghlan JG, Ghofrani HA, Grimminger F, et al
    Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2.
    Ann Rheum Dis. 2017;76:422-426.
    PubMed     Abstract available


    April 2016
  12. MIHAI C, Landewe R, van der Heijde D, Walker UA, et al
    Digital ulcers predict a worse disease course in patients with systemic sclerosis.
    Ann Rheum Dis. 2016;75:681-6.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: